Cadrenal Therapeutics
About:
Cadrenal Therapeutics develops a late-stage novel therapy for patients with end-stage renal disease and atrial fibrillation.
Website: https://www.cadrenal.com/
Description:
Cadrenal Therapeutics is a biopharmaceutical company developing a late-stage novel therapy for patients with end-stage renal disease and atrial fibrillation. The company was founded in 2022 and is headquartered in Ponte Vedra Beach, Florida.
Total Funding Amount:
$17.3M
Headquarters Location:
Ponte Vedra Beach, Florida, United States
Founded Date:
2022-01-01
Founders:
Number of Employees:
1-10
Last Funding Date:
2024-11-01
IPO Status:
Public
Industries:
© 2025 bioDAO.ai